We came across a bullish thesis on Braskem S.A. on Penny on the Dollar’s Substack. In this article, we will summarize the bulls’ thesis on BAK. Braskem S.A.'s share was trading at $3.7300 as of February 12th. BAK’s trailing and forward P/E were 8.44 and 9.78 respectively according to Yahoo Finance. Fluence Energy (FLNC) Jumps 21% Alongside Peers as JPMorgan Bares Trillion-Dollar Investment Photo by RawFilm on Unsplash Braskem S.A., a CCC-rated Brazilian petrochemical giant, trades at $2.86 per ADR, givi ...

以下文章来源于生物基智库 ，作者生物基能源与材料 生物基智库 . 生物基产业的推动者（生物基和生物制造产业服务平台www.bio-basedlink.net） 关键词| 生物基大会 | 旭化成、三井化学、三菱化学 摘要 ：三大日本化工巨头，投资212亿日元，关停现有乙烯装置，新建生物基烯烃装置 【 DT新材料 】 获 悉，1月27日， 旭化成 、 三井化学 和 三菱化学 已着手采取措施，以推动日本西部两家乙烯生产厂的低碳化进程，并优化其产 能。 为了实现这些目标，这三家公司在经济产业省（METI）的" 2025 财年难减排行业能源与制造工艺转型支持计划 "（HtA 支持计划）中申请并入选，并 将签署一份基本协议，以建立一个新的联合运营实体，总投资 212亿日元 （约合9.63亿元人民币），用于管理日本西部的这两座乙烯生产设施，并终 止 旭化成三菱化学乙烯公司（AMEC） 位于冈山县仓敷市的水岛工厂的乙烯生产设施的运营，并将运营整合至位于大阪市高西的大阪石化工业有限公 司（OPC）的设施中，目标是在 2030 财年实现这一目标。 来源：旭化成 以 2030年，日本水岛厂区将关停近乙烯生产装置，这些产能整合后将集 ...

Core Viewpoint - The Australian IPO market is currently facing challenges, with a lack of new listings and a recent withdrawal of Barkly Rare Earths from its planned IPO, indicating a continued struggle for new company listings despite some optimism in the metals market [1][2][5]. Group 1: IPO Market Status - Unity Metals recently listed on the ASX, marking the first IPO of the calendar year 2026 [1]. - Barkly Rare Earths has postponed its listing from January 22 to an indefinite status, contributing to a bleak outlook for new IPOs [1][5]. - The easing of ASX IPO listing rules last year has not significantly improved the situation, as the market still resembles the IPO drought experienced in late CY23 [2][3]. Group 2: Upcoming Listings - Two upcoming IPOs are scheduled for February: Eastern Gas Corporation aiming to raise $5.5 million and Macallum New Energy targeting $9 million, both categorized as smaller listings [6]. - There is a notable absence of larger, high-profile companies looking to list, with Canva confirming it will not pursue an ASX IPO, leaving investors awaiting a significant listing [6]. Group 3: Market Sentiment - Despite the recent enthusiasm in metals prices, the overall sentiment in the IPO market remains cautious, with stockbrokers returning from holidays in anticipation of new listings [2][4]. - The current environment suggests that investors who favor IPOs may find limited opportunities in the near term [5].

Group 1 - Petrobras and IG4 plan to implement alternate control over Brazilian chemical producer Braskem [1] - This strategic move indicates a shift in ownership dynamics within the Brazilian chemical industry [1] - The collaboration aims to enhance operational efficiency and market positioning for Braskem [1] Group 2 - The involvement of Petrobras, a state-controlled oil giant, highlights the significance of energy companies in the chemical sector [1] - IG4's participation suggests a growing interest from private equity in the Brazilian chemical market [1] - This development may lead to increased investment and innovation within Braskem, impacting the broader chemical industry landscape in Brazil [1]

Core Viewpoint - BofA has lowered the price target for Braskem (BAK) to $3.30 from $3.70, maintaining a Neutral rating due to recent legislative changes in Brazil that negatively impact the company's expected benefits [1] Group 1: Price Target Adjustment - BofA reduced the price target for Braskem from $3.70 to $3.30 [1] - The firm maintains a Neutral rating on Braskem shares following the price target adjustment [1] Group 2: Legislative Impact - Brazilian President sanctioned Draft Bill (PL) 892/2025, which establishes the PRESIQ benefit and the REIQ's rate schedule [1] - The proposed increase in REIQ for 2026 was vetoed, which was previously incorporated into the firm's expectations [1] - The analyst views the news as negative for Braskem, as it alters anticipated benefits for the company [1]

Core Viewpoint - Clariant has received damage claims totaling approximately EUR 548 million and EUR 402 million from MOL Petrolkémia Zrt. and Slovnaft a.s. (MOL Group) and Braskem S.A. regarding alleged competition law infringements in the ethylene purchasing market, which the company firmly rejects and plans to defend vigorously [1]. Company Overview - Clariant is a sustainability-focused specialty chemical company based in Switzerland, with a staff of 10,465 and recorded sales of CHF 4.152 billion in the fiscal year ending December 31, 2024 [5]. - The company operates through three business units: Care Chemicals, Catalysts, and Adsorbents & Additives, emphasizing customer focus, innovation, and sustainability [5].

Core Points - A class action lawsuit has been filed against Perrigo Company plc for alleged securities fraud and unlawful business practices [1] - Investors who purchased Perrigo securities during the Class Period can apply to be Lead Plaintiff by January 16, 2026 [2] - Perrigo reported significant financial challenges, including a 50% decline in earnings per share for fiscal year 2023 due to remediation costs in its infant formula business [2] - The company's stock price has experienced significant declines following negative earnings reports and strategic announcements, including a drop of 25.2% to close at $15.10 per share on November 5, 2025, after announcing a strategic review of its infant formula business [3] Financial Performance - For fiscal year 2023, Perrigo incurred one-time cash costs of $35 million to $45 million related to production issues in its infant formula business [2] - The adjusted gross profit for the second quarter ended June 28, 2025, decreased by $30 million, or 6.9%, attributed to production variability in infant formula [3] - The stock price fell by $4.87 per share (15.14%) on February 27, 2024, and by $3.28 per share (9.8%) on May 7, 2024, following negative earnings reports [2][3]

Core Viewpoint - A class action lawsuit has been filed against Freeport-McMoran Inc. concerning allegations of securities fraud and unlawful business practices related to a mining incident in Indonesia [2]. Group 1: Lawsuit Details - The lawsuit involves claims that Freeport and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until January 12, 2026, to request to be appointed as Lead Plaintiff if they purchased Freeport securities during the Class Period [2]. Group 2: Incident Overview - On September 9, 2025, Freeport announced the suspension of mining activities at its Grasberg Block Cave operation due to a large flow of wet material that trapped seven workers [2]. - Following this announcement, Freeport's stock price fell by $2.80 per share, or 5.99%, closing at $43.87 per share [2]. - On September 24, 2025, Freeport reported that two of the seven trapped workers were fatally injured and the remaining five were still missing, leading to a further stock price decline of $7.69 per share, or 16.95%, closing at $37.67 per share [2].

Group 1: Market Overview - The market conditions for most bulk and diversified chemical producers remain challenging, despite some signs of recent demand improvement in polymer production [1] - Long-term issues of oversupply and cost-cutting persist in the industry [1] Group 2: Polyolefins Market Performance - LyondellBasell reported an adjusted net income of $330 million, up from $202 million in the second quarter, driven by strong polyethylene (PE) sales and lower ethylene costs [2] - LyondellBasell noted that while PE profit margins improved due to cost reductions, polypropylene margins and sales remain weak; however, PE sales in the U.S. and Europe have begun to recover [2] - ExxonMobil also contributed to the positive performance in the polyolefins market, although specific figures were not detailed [2] Group 3: Company Financials - LyondellBasell's sales decreased by 10% to $7.73 billion, with a net income of -$890 million [3] - Nutrien's sales increased by 13% to $5.735 billion, with a net income of $464 million [3] - Mosaic reported a 25% increase in sales to $3.452 billion, with a net income of $411 million, a 237% increase [3] - Braskem's adjusted net income was $1.7 million, recovering from a loss of $89 million in the previous quarter, attributed to cost-cutting and a focus on higher-value sales [5]

Summary of Global Chemicals Conference Call Industry Overview - The global chemicals cycle is weakening beyond prior expectations, with caution heightened by the Braskem situation, indicating a need for additional due diligence and/or a higher risk premium [1][3] - The European chemical sector is losing competitiveness due to high energy costs, strict carbon policies, and persistent overcapacity, leading to plant closures and asset sales [3][16] - China's aggressive capacity expansion has created a global oversupply in chemicals, particularly in TiO2, PVC, ethylene, and polyethylene, driving down prices [6][8] Key Points European Chemical Sector - BASF's proactive restructuring and noncore asset sales are helping maintain its low-A ratings despite weak upstream margins [3] - Ineos Group Holdings and Ineos Quattro are experiencing rating downgrades due to operational weaknesses and inflated leverage [3] - The European chemical industry has seen output decline by over 50% since 2003, with natural gas prices in Europe being 3-4 times higher than in the US [16][22] - The EU's REACH regulation and the EU Emissions Trading System (EU ETS) are increasing compliance costs for European firms, further eroding competitiveness [21][22] Chinese Market Dynamics - China's share of global chemical capacity has surged from around 15% to nearly 50% over two decades, leading to a persistent supply-demand imbalance [8] - CMA projects that China will add significant ethylene capacity, exceeding current total capacity in Europe, exacerbating global oversupply [9][36] Demand Challenges - The automotive and construction sectors, critical end markets for chemical producers, are experiencing prolonged softness, negatively impacting chemical demand [12] - In the US, existing home sales have slowed significantly, and the European construction sector has contracted due to high interest rates and labor shortages [12] Braskem Case Study - Braskem's credit deterioration highlights risks in oversupplied chains and reliance on high-cost naphtha feedstock, with net leverage exceeding 10x [52][53] - The company has faced rapid downgrades, reflecting how quickly credit can deteriorate in a prolonged industry downturn [54][55] Latin American Chemical Credits - Latin American chemical credits face heightened risks from oversupply and weak spreads, with downgrades likely if earnings disappoint [6][59] - Orbia and Alpek have been downgraded to Market Weight, while Braskem remains Underweight due to deteriorating PVC fundamentals [69][71] North American Chemical Producers - US investment-grade chemical producers like DOW and LYB are seeing EBITDA collapse, with estimates for 2025 now 50% lower than a year prior [72][73] - The US high-yield chemical index has widened, underperforming the broader high-yield index due to exposure to chains affected by Chinese capacity issues [76] Trade Recommendations - Buy BASF 4.25% 2032s and sell Orbia 2030s due to heightened fallen angel risk [8][62] - Switch into SGLSJ 2029s from SASOL 2028s as part of a strategy to optimize exposure [8] Conclusion - The global chemicals sector is facing significant challenges from oversupply, weak demand, and regulatory pressures, particularly in Europe and North America. The situation is exacerbated by China's aggressive capacity expansion and the ongoing credit deterioration of key players like Braskem. Investors are advised to exercise caution and consider strategic trades to mitigate risks.